Emerging Viral Diseases: Confronting Threats with New Technologies
- 10 September 2014
- journal article
- perspective
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 6 (253) , 253ps10
Abstract
Emerging viral diseases continue to threaten human health, but recent scientific advances are better positioning us to treat them and to detect and control the causative pathogens.Keywords
This publication has 35 references indexed in Scilit:
- Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginningNature Reviews Immunology, 2013
- Gaps in the achievement of effectiveness of HCV treatment in national VA practiceJournal of Hepatology, 2012
- Broad-Spectrum Antiviral TherapeuticsPLOS ONE, 2011
- Ebola haemorrhagic feverThe Lancet, 2011
- Rapid Detection of Respiratory Tract Viral Infections and Coinfections in Patients with Influenza-Like Illnesses by Use of Reverse Transcription-PCR DNA Microarray SystemsJournal of Clinical Microbiology, 2010
- Emerging infections: a perpetual challengeThe Lancet Infectious Diseases, 2008
- A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trialVaccine, 2008
- Rational Approach to AIDS Drug Design Through Structural BiologyAnnual Review of Medicine, 2002
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989